Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Development and uptake of the 'CONSORT and SPIRIT Extension for RCTs reVised in Extenuating circumstances' (CONSERVE) statement 2021 for the reporting of trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances

Title: Development and uptake of the 'CONSORT and SPIRIT Extension for RCTs reVised in Extenuating circumstances' (CONSERVE) statement 2021 for the reporting of trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances
Authors: Orkin, A; Gill, P; Gehrsi, D; Campbell, L; Sugarman, J; Emsley, R; Steg, PG; Weijer, C; Simes, J; Rombey, T; Williams, H; Wittes, J; Moher, D; Richards, D; Kasamon, Y; Getz, K; Hopewell, S; Dickersin, K; Wu, T; Ayla, AP; Schulz, K; Calleja, S; Boutron, I; Ross, J; Golub, R; Khan, K; Mulrow, C; Siegfried, N; Heber, J; Lee, N; Kearney, PR; Wanyenze, R; Hróbjartsson, A; Williams, R; Bhandari, N; Jüni, P; Chan, AW
Source: Evidenzbasierte Medizin für eine bedarfsgerechte Gesundheitsversorgung; 23. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20220901-20220903; Lübeck; DOC22ebmVS-9-04 /20220830/
Publisher Information: German Medical Science GMS Publishing House; Düsseldorf
Publication Year: 2022
Collection: GMS e-journal - German Medical Science (Association of the Scientific Medical Societies in Germany)
Subject Terms: ddc: 610
Document Type: conference object
Language: English
Relation: Orkin AM, Gill PJ, Jüni P, Ghersi A, Chan A-W. Development Protocol - CONSORT and SPIRIT Extension for RCTs reVised in Extenuating Circumstances. OSF. 2021. DOI:10.17605/OSF.IO/MS8BZ; Orkin AM, Gill PJ, Ghersi D, Campbell L, Sugarman J, Emsley R, Steg PG, Weijer C, Simes J, Rombey T, Williams HC, Wittes J, Moher D, Richards DP, Kasamon Y, Getz K, Hopewell S, Dickersin K, Wu T, Ayala AP, Schulz KF, Calleja S, Boutron I, Ross JS, Golub RM, Khan KM, Mulrow C, Siegfried N, Heber J, Lee N, Kearney PR, Wanyenze RK, Hróbjartsson A, Williams R, Bhandari N, Jüni P, Chan AW; CONSERVE Group. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement. JAMA. 2021 Jul 20;326(3):257-65. DOI:10.1001/jama.2021.9941; http://dx.doi.org/10.3205/22ebm055; http://www.egms.de/en/meetings/ebm2022/22ebm055.shtml
DOI: 10.3205/22ebm055
Availability: https://doi.org/10.3205/22ebm055; http://nbn-resolving.de/urn:nbn:de:0183-22ebm0557; http://www.egms.de/en/meetings/ebm2022/22ebm055.shtml
Rights: http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.E8B65A7D
Database: BASE